メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
西本 祥仁
内科学(神経)
ウェブサイト
https://k-ris.keio.ac.jp/html/100007238_ja.html
h-index
1009
被引用数
17
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2007
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(40)
類似のプロファイル
(6)
フィンガープリント
Yoshinori Nishimotoが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
In Situ Hybridization
71%
Immunoelectron Microscopy
66%
Electron Microscopic
66%
Drosophila Ovary
66%
Japan
66%
Comorbidity
66%
Patients with multimorbidity
50%
Well-being
44%
Aging
44%
Kawasaki
44%
LncRNA NEAT1
33%
MiRNA Biogenesis
33%
Precise Location
33%
Myositis
33%
Very Old
33%
Ovarian Somatic Cells
33%
Nivolumab
33%
Community-dwelling
33%
Biological Applications
33%
Neurogenic Pulmonary Edema
33%
Life Satisfaction
33%
A-to-I Editing
33%
ADAR1
33%
Paraspeckles
33%
Long Non-coding RNA nuclear-enriched Abundant Transcript 1
33%
RNA-editing Enzymes
33%
Neuro-diseases
33%
PIWI-interacting RNA (piRNA)
33%
Amyloid PET
33%
Self-rated Health
33%
Health Satisfaction
33%
H2N2
33%
Longitudinal Cohort
33%
Cadherin-7
33%
Gold Particles
33%
Biogenesis
33%
Cohort Analysis
33%
Drosophilidae
33%
Human Primates
33%
Subcellular Localization
33%
Myasthenia Gravis
33%
Inclusion Bodies
33%
Older Persons
33%
Rodents
33%
Multimorbid
33%
Prospective Cohort Study
33%
Adenosine Deaminase Acting on RNA
27%
Pontine nuclei
26%
Chronic Conditions
18%
Specificity Protein 1
16%
Medicine and Dentistry
Multiple Chronic Conditions
100%
RNA Editing
66%
Wellbeing
40%
Alzheimer's Disease
40%
Patient Care
40%
Magnetic Resonance Imaging
38%
Cross Sectional Study
37%
Myositis
33%
Cell Line
33%
Nivolumab
33%
Amyloid
33%
Positron Emission Tomography
33%
Cohort Analysis
33%
Adenosine Deaminase
33%
Dural Arteriovenous Fistula
33%
Enzyme Defect
33%
Amyotrophic Lateral Sclerosis
33%
Self Rated Health
33%
ADAR
33%
Myasthenia gravis
33%
Respiratory Distress
33%
Corpus Callosum
33%
Splenium
33%
Cell Culture
33%
Tau
33%
Bleeding
33%
Centenarians
33%
Prospective Cohort Study
33%
Comorbidity
26%
Health Care Cost
20%
Polypharmacy
20%
Messenger RNA Precursor
20%
Hazard Ratio
20%
Symptom
17%
Immune Checkpoint Inhibitor
16%
Kv1.1
16%
Pulmonary Edema
16%
Mild Cognitive Impairment
13%
Outpatient
13%
Weakness
13%
Medulla Oblongata
13%
Arthritis
12%
Patient with Alzheimer's Disease
12%
Prevalence
10%
Health Outcomes
10%
Frailty
10%
Involuntary Movement
9%
Immunoglobulin
8%
Plasma Exchange
8%
Dyspnea
8%
Biochemistry, Genetics and Molecular Biology
Intravenous Immunoglobulin
66%
Electron Microscopy
66%
in Situ Hybridization
66%
Long Non-Coding RNA
66%
Piwi-Interacting RNA
66%
Biogenesis
66%
RNA
66%
Motor Neuron
57%
Induced Pluripotent Stem Cell
40%
Allele
35%
Serine Protease
33%
Autosomal Recessive Inheritance
33%
Testosterone Blood Level
33%
Paraspeckle
33%
Apolipoprotein
33%
RNA Editing
33%
Adenosine Deaminase Acting Rna
33%
Subcellular Localization
33%
Somatic Cell
33%
Nucleoporin
33%
FUS
33%
Nuclear Lamina
33%
Mental Health
33%
C9orf72
22%
Genome-Wide Association Study
22%
Animal Model
17%
Stress Granule
12%
Cell Death
11%
TAR DNA Binding Protein
11%
Precursor
11%
RNA-binding Protein
11%
Overall Survival
11%
E-Site
11%
Kv1.1
11%
Computational Genomics
11%
Non-Coding RNA
11%
Protein Repeat
11%
Dipeptide
11%
Caspase 3
11%
Single Nucleotide Polymorphism
11%
Apolipoprotein E
11%
Lower Motor Neuron
10%
Mortality Rate
9%
Missense Mutation
8%
Fusion Gene
6%
Genetic Regulation
6%
Stem Cell Line
6%
Protein Sequencing
6%
Mouse Model
6%
Alternative Splicing
6%
